Impax Transferring Products To Taiwan After GMP Warning Letter For U.S. Plant
This article was originally published in The Pink Sheet Daily
Executive Summary
Future applications involving the Hayward, Calif. plant targeted by warning letter on manufacturing practices may be stalled, but Phase III Parkinson's candidate IPX066 won't be affected, execs say.